Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prime Medicine, Inc. - Common Stock (NQ:PRME)

3.560 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 376
Open 3.560
Bid (Size) 3.500 (3,100)
Ask (Size) 3.600 (5,300)
Prev. Close 3.560
Today's Range 3.560 - 3.560
52wk Range 2.670 - 6.940
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Prime Medicine to Participate in Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire

Performance

YTD
+0.8%
+0.8%
1 Month
+13.0%
+13.0%
3 Month
+23.6%
+23.6%
6 Month
-12.1%
-12.1%
1 Year
-8.5%
-8.5%

More News

Read More
News headline image
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine (NASDAQ:PRME) Q1 Results Show Revenue Miss and Narrower Loss as Key Pipeline Milestones Loom ↗
Via Chartmill
News headline image
Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Present at Jefferies Global Healthcare Conference
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Participate in Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Present at 8th Annual Evercore Healthcare Conference
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Present at Jefferies Global Healthcare Conference
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Prime Medicine to Participate in Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design
Via TokenRing AI
Topics Artificial Intelligence

Frequently Asked Questions

Is Prime Medicine, Inc. - Common Stock publicly traded?
Yes, Prime Medicine, Inc. - Common Stock is publicly traded.
What exchange does Prime Medicine, Inc. - Common Stock trade on?
Prime Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Prime Medicine, Inc. - Common Stock?
The ticker symbol for Prime Medicine, Inc. - Common Stock is PRME on the Nasdaq Stock Market
What is the current price of Prime Medicine, Inc. - Common Stock?
The current price of Prime Medicine, Inc. - Common Stock is 3.560
When was Prime Medicine, Inc. - Common Stock last traded?
The last trade of Prime Medicine, Inc. - Common Stock was at 09/08/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.